CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-10 | Lanfear Dennis M President & CEO | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2020-01-10 | Vexler Vladimir Chief Scientific Officer | Grant or award | +8,900 | 28,412 | ||
| 2020-01-10 | Vexler Vladimir Chief Scientific Officer | Shares withheld for taxes | −3,477 | $17.73 | $62K | 24,935 |
| 2020-01-10 | Vexler Vladimir Chief Scientific Officer | Grant or award | +31,250 | 56,185 | ||
| 2020-01-10 | Vexler Vladimir Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +62,500 | 62,500 | ||
| 2020-01-10 | Viret Jean-Frederic Chief Financial Officer | Grant or award | +19,365 | 22,668 | ||
| 2020-01-10 | Viret Jean-Frederic Chief Financial Officer | Shares withheld for taxes | −7,077 | $17.73 | $125K | 15,591 |
| 2020-01-10 | Viret Jean-Frederic Chief Financial Officer | Grant or award | +31,250 | 46,841 | ||
| 2020-01-10 | Viret Jean-Frederic Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +62,500 | 62,500 | ||
| 2020-01-10 | Anicetti Vincent R Chief Operating Officer | Grant or award | +19,566 | 38,892 | ||
| 2020-01-10 | Anicetti Vincent R Chief Operating Officer | Shares withheld for taxes | −7,146 | $17.73 | $127K | 31,746 |
| 2020-01-10 | Anicetti Vincent R Chief Operating Officer | Grant or award | +31,250 | 62,996 | ||
| 2020-01-10 | Anicetti Vincent R Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +62,500 | 62,500 | ||
| 2020-01-09 | HEALY JAMES Director | Option exercise | +29,994 | $1.67 | $50K | 30,086 |
| 2020-01-09 | HEALY JAMES Director | Option exercise | +20,000 | $10.05 | $201K | 50,086 |
| 2020-01-09 | HEALY JAMES Director | Option exercise · Stock Option (Right to Buy) | −29,994 | 0 | ||
| 2020-01-09 | HEALY JAMES Director | Option exercise · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2019-12-16 | Anicetti Vincent R Chief Operating Officer | Option exercise | +2,500 | $2.50 | $6K | 21,826 |
| 2019-12-16 | Anicetti Vincent R Chief Operating Officer | Sale | −2,500 | $18.69 | $47K | 19,326 |
| 2019-12-16 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −2,500 | 34,988 |
Page 18 of 39 · 768 trades